As of December 19, tirzepatide is the only GLP-1 product being removed from the FDAs shortages list, while dulaglutide (Trulicity), semaglutide (Ozempic/Wegovy) and liraglutide (Victoza/Saxenda) remain listed as in shortage. Victoza Goes Generic As of June 2024, Teva launched its generic version of the diabetic GLP-1 medication Victoza, liraglutide
Use of glucagon-like peptide-1 receptor agonists for pediatric patients with obesity and diabetes: The providers perspectives
By Nancy Lapid July 22 (Reuters) The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest
Deglutathionylation Deglutathionylation undergoes cleavage of the disulfide linkage of the glutathionylated protein with another GSH molecule (Figure 3)
Gossop, M., Griffiths, P., Powis, B
By these mechanisms, GLP-1 medications help in lowering blood glucose levels and supporting weight loss